College of Medicine
Boye Lab
Led by Shannon E Boye · Pediatrics
What we study
The Boye Lab studies gene therapies using viral vectors, like adeno-associated viruses (AAVs), to treat inherited eye diseases. They develop new AAV capsids, dual-vector platforms, and CRISPR-based therapies, testing them in animal models and macaques.
What working here is like
- Wet lab
- Mice
- Projects
- 5
Current projects
AAV-based gene therapies for LCA1, Usher syndrome 1B, and XLRS
Developing AAV vectors to treat inherited eye diseases like LCA1 and Usher syndrome.
Novel AAV capsids for foveal cone delivery
Creating safer and more efficient AAV capsids to deliver genes to the fovea.
Show 3 more projectsShow fewer
Dual AAV vector platforms for large transgenes
Designs dual AAV gene therapy vectors that split a large gene across two viruses, so large genes can be delivered, with a focus on inherited eye diseases.
AAV-CRISPR therapies for dominant retinal diseases
Using CRISPR with AAVs to treat dominant inherited retinal diseases.
AAV-based therapy for Friedreich’s Ataxia
Developing an AAV-based gene therapy for the eye symptoms of Friedreich’s Ataxia.
Summaries are written by AI in plain language from public symposium abstracts and may be imperfect.
How to reach out
Shannon E Boye hasn't set up this page yet. Their UF Scholars profile lists their publications.